Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Flavio Vincenti

Showing results (21-30 of 132) with videos related to

Pageof 14
Sort By:
Current Opinion in Organ Transplantation|October 10, 2012
Belatacept in kidney transplantationDavid Wojciechowski, Flavio Vincenti
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 9, 2024
Antiplasma cell antibodies: A new era of human leukocyte antigen antibody control in solid organ transplantationSindhu Chandran, Flavio Vincenti
Annual Review of Medicine|October 6, 2006
T cell costimulation: a rational target in the therapeutic armamentarium for autoimmune diseases and transplantationFlavio Vincenti, Michael Luggen
Seminars in Liver Disease|July 20, 2006
Immunosuppression: today, tomorrow, and withdrawalRyutaro Hirose, Flavio Vincenti
Transplantation|October 28, 2005
Toxicity-sparing protocols using mycophenolate mofetil in renal transplantationWalter Land, Flavio Vincenti
Cold Spring Harbor Perspectives in Medicine|December 28, 2013
Clinical aspects: focusing on key unique organ-specific issues of renal transplantationSindhu Chandran, Flavio Vincenti
Contemporary Clinical Trials|April 20, 2005
Rationale and design of the DIRECT study: a comparative assessment of the hyperglycemic effects of tacrolimus and cyclosporine following renal transplantationFlavio Vincenti, Lionel Rostaing,
The Journal of Clinical Investigation|July 1, 2017
Transplant trials with Tregs: perils and promisesQizhi Tang, Flavio Vincenti
Biologics : Targets & Therapy|November 16, 2012
Belatacept for prevention of acute rejection in adult patients who have had a kidney transplant: an updateDavid Wojciechowski, Flavio Vincenti
Seminars in Nephrology|July 10, 2007
Novel immunosuppression: small molecules and biologicsJulie M Yabu, Flavio Vincenti
Pageof 14

Showing results (21-30 of 132) with videos related to

Sort By:
Pageof 14
Current Opinion in Organ Transplantation|October 10, 2012
Belatacept in kidney transplantationDavid Wojciechowski, Flavio Vincenti
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 9, 2024
Antiplasma cell antibodies: A new era of human leukocyte antigen antibody control in solid organ transplantationSindhu Chandran, Flavio Vincenti
Annual Review of Medicine|October 6, 2006
T cell costimulation: a rational target in the therapeutic armamentarium for autoimmune diseases and transplantationFlavio Vincenti, Michael Luggen
Seminars in Liver Disease|July 20, 2006
Immunosuppression: today, tomorrow, and withdrawalRyutaro Hirose, Flavio Vincenti
Transplantation|October 28, 2005
Toxicity-sparing protocols using mycophenolate mofetil in renal transplantationWalter Land, Flavio Vincenti
Cold Spring Harbor Perspectives in Medicine|December 28, 2013
Clinical aspects: focusing on key unique organ-specific issues of renal transplantationSindhu Chandran, Flavio Vincenti
Contemporary Clinical Trials|April 20, 2005
Rationale and design of the DIRECT study: a comparative assessment of the hyperglycemic effects of tacrolimus and cyclosporine following renal transplantationFlavio Vincenti, Lionel Rostaing,
The Journal of Clinical Investigation|July 1, 2017
Transplant trials with Tregs: perils and promisesQizhi Tang, Flavio Vincenti
Biologics : Targets & Therapy|November 16, 2012
Belatacept for prevention of acute rejection in adult patients who have had a kidney transplant: an updateDavid Wojciechowski, Flavio Vincenti
Seminars in Nephrology|July 10, 2007
Novel immunosuppression: small molecules and biologicsJulie M Yabu, Flavio Vincenti
Pageof 14